VOGLIDIN 0.2
VOGLIDIN 0.2 contains Voglibose 0.2 mg, an alpha-glucosidase inhibitor used in the treatment of type 2 diabetes to control post-meal blood sugar spikes. It works by slowing carbohydrate digestion in the intestine, reducing the rapid rise of glucose after meals. VOGLIDIN 0.2 helps improve postprandial sugar control and supports better overall glycemic management in diabetic patients.
Related products
SITAMATA 50-500
SITAMATA 50-500 contains Sitagliptin 50 mg + Metformin Hydrochloride 500 mg, a balanced combination used...
SITAMATA 50- 1000
Compositins : Each Film Coated Bilayered Tablet Contains: Sitagliptin Phosphate Monohydrate IP Eq to Sitagliptin...
LINANTA M 500
LINANTA M 500 combines Linagliptin 2.5 mg + Metformin Hydrochloride 500 mg, offering dual-action support...
GLYZIL M
GLYZIL M is a trusted combination for managing type 2 diabetes mellitus effectively. Each tablet...
DUET ACT 2
DUET ACT 2 combines Glimepiride 2 mg with Metformin 500 mg (SR) for better blood...
DUET ACT 1
DUET ACT 1 contains Glimepiride 1 mg and Metformin 500 mg (SR). It works by...
DAPAGLIDE M 1000
DAPAGLIDE M 1000 Tablet is a combination medicine used for managing type 2 diabetes effectively....
CARBOSTOP 50
CARBOSTOP 50 Tablet is a combination medicine used for managing type 2 diabetes effectively. It...
